science
plus
.abes.fr
|
explorer
À propos de :
Spotlight Issue on: The Role of the Ubiquitin-Proteasome Pathway in Cardiovascular Disease
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
bibo:Issue
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
work
Issue
New Facet based on Instances of this Class
Attributs
Valeurs
type
work
Issue
Is Part Of
http://hub.abes.fr/oup/periodical/cardiovascres/2010/volume_85
Title
Spotlight Issue on: The Role of the Ubiquitin-Proteasome Pathway in Cardiovascular Disease
has manifestation of work
http://hub.abes.fr/oup/periodical/cardiovascres/2010/volume_85/issue_2/m/print
http://hub.abes.fr/oup/periodical/cardiovascres/2010/volume_85/issue_2/m/web
Date Copyrighted
2010
Rights
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.
issue
2
Access Rights
creative-commons
is
Is Part Of
of
Aims and Scope
SPOTLIGHT ISSUE ON The Role of the Ubiquitin-Proteasome Pathway in Cardiovascular Disease
The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy
Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2
Functional alterations of cardiac proteasomes under physiological and pathological conditions
The ubiquitin-proteasome system in myocardial ischaemia and preconditioning
Editorial Board
The ubiquitin-proteasome pathway and endothelial (dys)function
The role of the ubiquitin-proteasome pathway in cardiovascular disease
Contents Page
The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective
Stressing the ubiquitin-proteasome system
Announcement: Review Focus on Mitochondria in Cardiac Disease: Emerging Concepts and Novel Therapeutic Targets
Regulation of the endothelial cell cycle by the ubiquitin-proteasome system
Proteasome inhibition during myocardial infarction
Ischaemic preconditioning improves proteasomal activity and increases the degradation of δPKC during reperfusion
Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms
Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy
On to the road to degradation: atherosclerosis and the proteasome
Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors
Proteasome inhibitors and cardiac cell growth
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
